PAVmed (PAVM) Non-Current Debt (2017 - 2026)

PAVmed (PAVM) posted quarterly Non-Current Debt of $100000.0 for Q3 2020, down 99.38% quarter-over-quarter from $16.2 million in Q2 2020.

PAVmed (PAVM) Non-Current Debt (2017 - 2026) Analysis & Trends

PAVmed's Non-Current Debt history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2020.

In Q3 2020, Non-Current Debt changed N/A year-over-year to $100000.0; the TTM figure through Sep 2020 stood at $100000.0 (changed N/A YoY), while the FY2019 annual figure was $8.1 million, changed N/A from the prior year.
Non-Current Debt for Q3 2020 stood at $100000.0, down from $16.2 million in the prior quarter.
The five-year high for Non-Current Debt was $16.2 million in Q2 2020, with the low at $20663.0 in Q1 2020.
The 4-year median for Non-Current Debt is $1.9 million (2017), against an average of $4.3 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn	29.60 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn	14.19 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn	10.92 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn	10.09 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn	7.34 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn	1.65 Bn
10	PAVmed	32.79 Mn	29.00 Mn	-89,000.00	15.10 Mn

Download Data